From this targeted exome association analysis, the protein-truncating variant in HSD17B13 (rs72613567) was found to confer lower odds across all categories of liver disease and provide protection against liver fibrosis in an allele dose-dependent manner. This evidence concerns the gene HSD17B13 and Hepatic fibrosis.